290 related articles for article (PubMed ID: 6243416)
21. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
Trottier MD; Palian BM; Reiss CS
Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
[TBL] [Abstract][Full Text] [Related]
22. Comparison of vesicular stomatitis virus defective interfering particle synthesis in chick embryo and L cells.
Potter KN; Stewart RB
Can J Microbiol; 1976 Oct; 22(10):1458-63. PubMed ID: 184896
[TBL] [Abstract][Full Text] [Related]
23. Modulation of glycosylation and transport of viral membrane glycoproteins by a sodium ionophore.
Alonso-Caplen FV; Compans RW
J Cell Biol; 1983 Sep; 97(3):659-68. PubMed ID: 6309867
[TBL] [Abstract][Full Text] [Related]
24. Persistence of vesicular stomatitis virus in interferon-treated cell cultures.
Thacore HR; Youngner JS
Virology; 1975 Feb; 63(2):345-51. PubMed ID: 163524
[No Abstract] [Full Text] [Related]
25. Mode of action of acid pH values on the development of vesicular stomatitis virus.
Fiszman M; Leaute JB; Chany C; Girard M
J Virol; 1974 Apr; 13(4):801-8. PubMed ID: 4132389
[TBL] [Abstract][Full Text] [Related]
26. Utilization of homotypic and heterotypic proteins of vesicular stomatitis virus by defective interfering particle genomes for RNA replication and virion assembly: implications for the mechanism of homologous viral interference.
Kim GN; Kang CY
J Virol; 2005 Aug; 79(15):9588-96. PubMed ID: 16014921
[TBL] [Abstract][Full Text] [Related]
27. Intracellular events in the replication of defective interfering particles of vesicular stomatitis virus.
Moyer SA; Gatchell SH
Virology; 1979 Jan; 92(1):168-79. PubMed ID: 217161
[No Abstract] [Full Text] [Related]
28. The target reaction in the antiviral action of mouse interferon against vesicular stomatitis virus multiplication.
Hoshino M; Taira H; Hattori S; Kawakita M
J Biochem; 1987 Mar; 101(3):685-94. PubMed ID: 2439495
[TBL] [Abstract][Full Text] [Related]
29. The calcium ionophore A23187 evokes and potentiates antiviral activity of interferon.
Maheshwari RK; Husain MM; Friedman RM; Krishna G
J Interferon Res; 1985; 5(4):605-12. PubMed ID: 2418129
[TBL] [Abstract][Full Text] [Related]
30. Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines.
Allen PT; Schellekens H; Van Griensven LJ; Billiau A
J Gen Virol; 1976 Jun; 31(3):429-35. PubMed ID: 58965
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of vesicular stomatitis viral mRNA synthesis by interferons.
Belkowski LS; Sen GC
J Virol; 1987 Mar; 61(3):653-60. PubMed ID: 3027394
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of vesicular stomatitis virus replication in dexamethasone-treated L929 cells.
Lancz G; Whitaker-Dowling P; Marsh YV; Bradley G; Eppstein DA; Hackney JF; Hulick-Swardstrom B
Proc Soc Exp Biol Med; 1990 Mar; 193(3):190-6. PubMed ID: 2154755
[TBL] [Abstract][Full Text] [Related]
33. Effect of combined alpha IFN and prostaglandin A1 treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells.
Pica F; Rossi A; Santirocco N; Palamara A; Garaci E; Santoro MG
Antiviral Res; 1996 Mar; 29(2-3):187-98. PubMed ID: 8739598
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of vesicular stomatitis virus-induced cytopathic effects. I. Early morphologic changes induced by infectious and defective-interfering particles.
Baxt B; Bablanian R
Virology; 1976 Jul; 72(2):370-82. PubMed ID: 181906
[No Abstract] [Full Text] [Related]
35. Delayed formation of defective interfering particles in vesicular stomatitis virus-infected cells: kinetic studies of viral protein and RNA synthesis during autointerference.
Von Laer DM; Mack D; Kruppa J
J Virol; 1988 Apr; 62(4):1323-9. PubMed ID: 2831393
[TBL] [Abstract][Full Text] [Related]
36. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein.
Santoro MG; Jaffe BM; Esteban M
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2797-801. PubMed ID: 6198441
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of vesicular stomatitis virus multiplication in Vero cells by 2-deoxy-D-glucose.
Sabina LR; Telasco CE
Acta Virol; 1979 May; 23(3):210-20. PubMed ID: 41433
[TBL] [Abstract][Full Text] [Related]
39. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
[TBL] [Abstract][Full Text] [Related]
40. Very rapid generation/amplification of defective interfering particles by vesicular stomatitis virus variants isolated from persistent infection.
DePolo NJ; Holland JJ
J Gen Virol; 1986 Jun; 67 ( Pt 6)():1195-8. PubMed ID: 3011977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
